Singapore markets closed
Straits Times Index
3,394.21 +17.02 (+0.50%) Nikkei
27,382.56 +19.81 (+0.07%) Hang Seng
22,688.90 +122.12 (+0.54%) FTSE 100
7,765.15 +4.04 (+0.05%) BTC-USD
23,119.46 +268.48 (+1.17%) CMC Crypto 200
526.66 +9.65 (+1.87%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 757.95M |
| Enterprise value | 174.45M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 19.05 |
| Price/book (mrq) | 0.92 |
| Enterprise value/revenue | 4.46 |
| Enterprise value/EBITDA | -0.86 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -42.25% |
| S&P500 52-week change 3 | -10.08% |
| 52-week high 3 | 8.7400 |
| 52-week low 3 | 2.7400 |
| 50-day moving average 3 | 3.5621 |
| 200-day moving average 3 | 5.4253 |
Share statistics
| Avg vol (3-month) 3 | 1.19M |
| Avg vol (10-day) 3 | 1.11M |
| Shares outstanding 5 | 249.33M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 147.65M |
| % held by insiders 1 | 15.74% |
| % held by institutions 1 | 66.10% |
| Shares short (12 Jan 2023) 4 | 17.96M |
| Short ratio (12 Jan 2023) 4 | 12.92 |
| Short % of float (12 Jan 2023) 4 | 10.33% |
| Short % of shares outstanding (12 Jan 2023) 4 | 7.20% |
| Shares short (prior month 14 Dec 2022) 4 | 17.11M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -559.17% |
Management effectiveness
| Return on assets (ttm) | -12.57% |
| Return on equity (ttm) | -28.61% |
Income statement
| Revenue (ttm) | 39.12M |
| Revenue per share (ttm) | 0.16 |
| Quarterly revenue growth (yoy) | -99.90% |
| Gross profit (ttm) | 10.65M |
| EBITDA | -201.2M |
| Net income avi to common (ttm) | -258.43M |
| Diluted EPS (ttm) | 1.4700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 648.13M |
| Total cash per share (mrq) | 2.6 |
| Total debt (mrq) | 67.47M |
| Total debt/equity (mrq) | 8.23 |
| Current ratio (mrq) | 12.88 |
| Book value per share (mrq) | 3.29 |
Cash flow statement
| Operating cash flow (ttm) | -162.5M |
| Levered free cash flow (ttm) | -73.14M |
© 2023 Yahoo. All rights reserved.
